|
Volumn 39, Issue 3, 2001, Pages 281-282
|
Genotyping method for point mutation detection in the endothelial nitric-oxide synthase exon 7 using fluorescent probes. Clinical validation in systemic sclerosis patients
a a a a a a a a |
Author keywords
Fluorescent probes; NO synthase exon 7 polymorphism; Systemic sclerosis
|
Indexed keywords
ACRYLAMIDE;
ADENINE;
ASPARTIC ACID;
DEOXYADENOSINE TRIPHOSPHATE;
DEOXYURIDINE;
DNA;
EDETIC ACID;
ETHIDIUM BROMIDE;
FLUORESCENT DYE;
GLUTAMIC ACID;
NITRIC OXIDE SYNTHASE;
REAGENT;
RESTRICTION ENDONUCLEASE;
RHODAMINE;
THYMINE;
ADULT;
AGED;
ALLELE;
ASSAY;
CONTROLLED STUDY;
DNA CONTENT;
EXON;
EXTRACTION;
FEMALE;
FLUORESCENCE;
GENE AMPLIFICATION;
GENE FREQUENCY;
GENETIC POLYMORPHISM;
GENETIC SUSCEPTIBILITY;
GENOTYPE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MISSENSE MUTATION;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RAYNAUD PHENOMENON;
SYSTEMIC SCLEROSIS;
VALIDATION PROCESS;
VASCULAR ENDOTHELIUM;
ADULT;
EXONS;
FEMALE;
FLUORESCENT DYES;
GENOTYPE;
HUMANS;
MALE;
MIDDLE AGED;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
POLYMORPHISM, GENETIC;
REPRODUCIBILITY OF RESULTS;
SCLERODERMA, SYSTEMIC;
|
EID: 0035034922
PISSN: 14346621
EISSN: None
Source Type: Journal
DOI: 10.1515/CCLM.2001.043 Document Type: Letter |
Times cited : (11)
|
References (10)
|